Results 21 to 30 of about 354,830 (305)

A note on clinical presentations of amebic liver abscess: an overview from 62 Thai patients [PDF]

open access: yes, 2002
Background Amebic liver abscess is a tropical disease with a wide spectrum of clinical presentations. Given the often nonspecific nature of the complaints related to amebic abscess, a retrospective review of patients with confirmed disease to recognize ...
Viroj Wiwanitkit   +13 more
core   +2 more sources

Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy. [PDF]

open access: yes, 2017
Gene therapy by engineering patient's own blood cells to confer HIV resistance can potentially lead to a functional cure for AIDS. Toward this goal, we have previously developed an anti-HIV lentivirus vector that deploys a combination of shRNA, ribozyme ...
Castanotto, Daniela   +4 more
core   +1 more source

Antibacterial, Anti-HIV-1 Protease and Cytotoxic Activities of Aqueous Ethanolic Extracts from Combretum Adenogonium Steud. Ex A. Rich (Combretaceae). [PDF]

open access: yes, 2012
\ud \ud Records have shown that Combretum adenogonium Steud. Ex A. Rich (Combretaceae) is used in traditional medicine systems of several tribes in Tanzania. This study focused on the investigation of antibacterial activity, anti-HIV-1 protease activity,
A Sartoratto   +34 more
core   +3 more sources

New findings on the d(TGGGAG) sequence: Surprising anti-HIV-1 activity [PDF]

open access: yes, 2018
The biological relevance of tetramolecular G-quadruplexes especially as anti-HIV agents has been extensively reported in the literature over the last years. In the light of our recent results regarding the slow G-quadruplex folding kinetics of ODNs based
Di Fabio, Giovanni   +5 more
core   +1 more source

Kan vericilerde HBsAg, anti-HCV, anti-HIV ve Sifilis seroprevalansı

open access: yesSakarya Tıp Dergisi, 2011
Bu çalışmada Afyon Kocatepe Üniversitesi Tıp Fakültesi Kan Merkezi'ne başvuran donörlerde HBsAg, anti-HCV, anti-HIV 1/2 ve RPR seroprevalansının tespiti ve oranların yıllara ve cinsiyete göre dağılımının belirlenmesi amaçlanmıştır.
Mustafa Altındiş   +2 more
doaj   +1 more source

Optimization of diarylazines as anti-HIV agents with dramatically [PDF]

open access: yes, 2013
Non-nucleoside inhibitors of HIV-1 reverse transcriptase are reported that have ca. 100-fold greater solubility than the structurally related drugs etravirine and rilpivirine, while retaining high anti-viral activity.
Anderson, Karen S.   +4 more
core   +1 more source

Modern anti-HIV therapy

open access: yesSwiss Medical Weekly, 2001
Highly active antiretroviral therapies (HAART), usually consisting of two nucleoside reverse transcriptase inhibitors (NRTI) plus an HIV protease inhibitor (PI), have been widely used since 1996. They produce durable suppression of viral replication with undetectable plasma levels of HIV-RNA in more than half of patients.
Flepp, Markus   +3 more
openaire   +4 more sources

Interaction of drugs of abuse and microRNA with HIV: a brief review. [PDF]

open access: yes, 2015
MicroRNAs (miRNAs), the post-transcriptional regulators of gene expression, play key roles in modulating many cellular processes. The changes in the expression profiles of several specific miRNAs affect the interactions between miRNA and their targets in
Nair, Madhavan P.N.   +1 more
core   +4 more sources

Presence of IgG anti-gp160/120 antibodies confers higher HIV capture capacity to erythrocytes from HIV-positive individuals. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: HIV binding has been demonstrated in erythrocytes from HIV-positive and HIV-negative individuals. However, the presence of immunoglobulins G anti-HIV (IgG anti-HIV) in erythrocytes from HIV-positive individuals is still to be elucidated ...
Maria Noé Garcia   +5 more
doaj   +1 more source

Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection

open access: yesViruses, 2022
HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) area key component of the current HIV-1 combination drug regimens. Although they exhibit potent anti-HIV-1 activity and modest toxicity, the emergence of mutant strains limits their ...
Dongwei Kang   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy